Adhera Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Adhera Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • Adhera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.54M, a 96.1% decline year-over-year.
  • Adhera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$4.49M, a 30.1% decline year-over-year.
  • Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.11M, a 66.7% increase from 2021.
  • Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.35M, a 68.6% decline from 2020.
  • Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$3.77M, a 68.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$4.49M -$3.54M -$1.73M -96.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$2.75M $271K +$173K +176% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-20
Q1 2023 -$2.93M -$886K -$812K -1101% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-20
Q4 2022 -$2.11M -$335K +$1.33M +79.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$3.45M -$1.8M +$1.94M +51.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$5.38M $98.3K +$612K Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-20
Q1 2022 -$6M -$73.7K +$354K +82.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-20
Q4 2021 -$6.35M -$1.67M -$1.19M -246% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$5.16M -$3.74M -$3.2M -594% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.96M -$514K +$392K +43.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$2.36M -$428K +$1.41M +76.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$3.77M -$483K +$3.6M +88.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$7.37M -$539K +$2.02M +78.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$9.38M -$906K +$1.87M +67.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 -$11.3M -$1.84M +$720K +28.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 -$12M -$4.08M -$1.12M -37.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 -$10.9M -$2.56M +$5.22M +67.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
Q2 2019 -$16.1M -$2.78M +$1.87M +40.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-18
Q1 2019 -$18M -$2.56M -$1.2M -88% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-18
Q4 2018 -$16.8M -$2.97M +$26.2K +0.88% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$16.8M -$7.78M -$6.81M -700% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$9.97M -$4.65M -$3.48M -297% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-19
Q1 2018 -$6.5M -$1.36M -$278K -25.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-19
Q4 2017 -$6.22M -$2.99M -$2.5M -505% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$3.72M -$972K -$873K -883% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 -$2.85M -$1.17M -$1.04M -806% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$1.81M -$1.08M -$969K -848% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-18
Q4 2016 -$837K -$495K +$3.39M +87.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$4.23M -$98.9K -$1.56M -107% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$2.67M -$129K -$1.03M -114% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$1.64M -$114K -$528K -128% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$1.11M -$3.89M -$9.69M -167% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $8.58M $1.46M +$8.58M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 -$2K $904K -$3.02M -76.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $3.02M $414K +$9.49M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$6.48M $5.8M +$7.77M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$14.2M -$7.12M -$6.15M -630% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$8.1M $3.92M +$3.93M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$12M -$9.08M -$10.5M -760% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$1.57M -$1.96M +$2.09M +51.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-18
Q3 2013 -$3.66M -$976K +$774K +44.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.43M -$7K -$1.09M -101% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 -$3.35M $1.38M +$6.2M Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-19
Q4 2012 -$9.55M -$4.05M +$13.7M +77.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-08-05
Q3 2012 -$23.3M -$1.75M +$2.64M +60.1% Jul 1, 2012 Sep 30, 2012 10-Q 2014-08-07
Q2 2012 -$25.9M $1.08M +$4.67M Mar 31, 2012 Jun 30, 2012 10-Q 2014-08-07
Q1 2012 -$30.6M -$4.82M -$1.16M -31.6% Jan 1, 2012 Mar 31, 2012 10-Q 2014-08-07
Q4 2011 -$29.4M -$17.8M Oct 1, 2011 Dec 31, 2011 10-K 2014-07-22
Q3 2011 -$4.39M +$3.89M +47% Jul 1, 2011 Sep 30, 2011 10-Q 2012-12-05
Q2 2011 -$3.59M +$516K +12.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-12-05
Q1 2011 -$3.67M Jan 1, 2011 Mar 31, 2011 10-Q 2012-12-05
Q3 2010 -$8.27M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$4.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.